Form D · Private Equity Fund

Abingworth Clinical Co-Development Co-Investment Fund, L.P.

Washington, DC · CIK 0001986436

Offering snapshot reported Nov 17, 2023 · SEC filing

Reported sold
$346M
Indefinite offering
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 25, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors0 → 18

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 17, 2023Amendment$346,405,000No comparison18SEC filing
Aug 21, 2023InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$595K (estimated)
Finders' fees
$0
Form D file number
021-490264
Total amount sold includes commitment from the feeder fund.
Sales commission includes amounts earned with respect to CCD-CIF Holdings, L.P.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
TCG Capital Markets L.L.C.291767TCG Capital Markets L.L.C. · CRD 291767
Asante Capital Group Advisors, LLC155178Asante Capital Group Advisors, LLC · CRD 155178

Source: Form D, filed Nov 17, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

ABINGWORTH BIOVENTURES 9

Investment adviser: CARLYLE INVESTMENT MANAGEMENT L.L.C.

Gross asset value
$63.8M
Beneficial owners
98
ADV minimum commitment
$25M

Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor ERNST & YOUNG LLP TYSONS, Virginia, United States Other funds reporting this name →
Custodian BANK OF AMERICA, NA (NEW YORK) NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Custodian SOCIETE GENERALE (LUXEMBOURG) LUXEMBOURG, Luxembourg Related to adviser: No Other funds reporting this name →
Marketer ASANTE CAPITAL GROUP ADVISORS, LLC NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Marketer TCG CAPITAL MARKETS L.L.C. NEW YORK, New York, United States Related to adviser: Yes Other funds reporting this name →
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
Yes

ERNST & YOUNG LLP
PCAOB 42

TCG CAPITAL MARKETS L.L.C.
CRD 291767 · SEC 8-70061

Fund asset history · 3 annual observations Gross asset value by annual ADV filing$0$31.9M$63.8MFY 2023: $0.00FY 2023FY 2024: $14,174,978.00FY 2024FY 2025: $63,789,888.00FY 2025

Scroll to see all columns →

Fiscal yearGross assetsBeneficial ownersADV filed
2023$010Mar 27, 2024
2024$14,174,97810Mar 31, 2025
2025$63,789,88898Mar 31, 2026
Filing source

Form ADV 2115592 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-1258408468

Reported by CARLYLE INVESTMENT MANAGEMENT L.L.C. (CRD 111128).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

Matched by reported Form D file number

ABINGWORTH CLINICAL CO-DEVELOPMENT CO-INVESTMENT FUND

Investment adviser: CARLYLE INVESTMENT MANAGEMENT L.L.C.

Gross asset value
$158M
Beneficial owners
55
ADV minimum commitment
$25M

Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor ERNST & YOUNG LLP TYSONS, Virginia, United States Other funds reporting this name →
Custodian BANK OF AMERICA, NA NEW YORK, New York, United States Related to adviser: No Other funds reporting this name →
Custodian BARCLAYS BANK PLC (LONDON) LONDON, United Kingdom Related to adviser: No Other funds reporting this name →
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

ERNST & YOUNG LLP
PCAOB 42

Fund asset history · 3 annual observations Gross asset value by annual ADV filing$0$79M$158MFY 2023: $57,510,287.00FY 2023FY 2024: $75,033,386.00FY 2024FY 2025: $157,976,829.00FY 2025

Scroll to see all columns →

Fiscal yearGross assetsBeneficial ownersADV filed
2023$57,510,28740Mar 27, 2024
2024$75,033,38640Mar 31, 2025
2025$157,976,82955Mar 31, 2026
Filing source

Form ADV 2115592 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-5336050518

Reported by CARLYLE INVESTMENT MANAGEMENT L.L.C. (CRD 111128).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeremy Anderson Executive
N/A Ccd Cif General Partner, L.P. Promoter
N/A Ccd Cif, L.L.C. Promoter
Christina Gibbs Executive
Elizabeth Muscarella Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
1001 Pennsylvania Avenue, Nw Suite 220 South
Washington, DC, 20004
Phone: 202-729-5626